A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial.

MLA

Zethraeus, Niklas, et al. “A First-Choice Combined Oral Contraceptive Influences General Well-Being in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Trial.” Fertility & Sterility, vol. 107, no. 5, May 2017, pp. 1238–45. EBSCOhost, https://doi.org/10.1016/j.fertnstert.2017.02.120.

APA

Zethraeus, N., Dreber, A., Ranehill, E., Blomberg, L., Labrie, F., von Schoultz, B., Johannesson, M., & Hirschberg, A. L. (2017). A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. Fertility & Sterility, 107(5), 1238–1245. https://doi.org/10.1016/j.fertnstert.2017.02.120

Chicago

Zethraeus, Niklas, Anna Dreber, Eva Ranehill, Liselott Blomberg, Fernand Labrie, Bo von Schoultz, Magnus Johannesson, and Angelica Lindén Hirschberg. 2017. “A First-Choice Combined Oral Contraceptive Influences General Well-Being in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Trial.” Fertility & Sterility 107 (5): 1238–45. doi:10.1016/j.fertnstert.2017.02.120.